Foundation Medicine to Present at Upcoming Investor Conferences

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Foundation Medicine, Inc. (NASDAQ: FMI) today announced that members of the company's management team will present at the following upcoming investor conferences:

• The Goldman Sachs Global Healthcare Conference on Tuesday, June 9, 2015, in Rancho Palos Verdes, Calif. (1x1s only).
• The William Blair Growth Stock Conference on Thursday, June 11, 2015, at 8:40 a.m. C.T. in Chicago.
• The JMP Securities Life Sciences Conference on Wednesday, June 24, 2015, at 4:00 p.m. E.T. in New York City.

Live, listen-only webcasts of the presentations may be accessed by visiting the investors section of the company’s website at investors.foundationmedicine.com. Replays of the webcasts will be available shortly after the conclusion of the presentations and will be archived on the company's website for two weeks.

About Foundation Medicine

Foundation Medicine (NASDAQ: FMI) is a molecular information company dedicated to a transformation in cancer care in which treatment is informed by a deep understanding of the genomic changes that contribute to each patient's unique cancer. The company's clinical assays, FoundationOne® for solid tumors and FoundationOne® Heme for hematologic malignancies and sarcomas, provide a comprehensive genomic profile to identify the molecular alterations in a patient's cancer and match them with relevant targeted therapies and clinical trials. Foundation Medicine's molecular information platform aims to improve day-to-day care for patients by serving the needs of clinicians, academic researchers and drug developers to help advance the science of molecular medicine in cancer. For more information, please visit http://www.FoundationMedicine.com or follow Foundation Medicine on Twitter (@FoundationATCG).

Foundation Medicine® and FoundationOne® are registered trademarks of Foundation Medicine, Inc.

View source version on businesswire.com: http://www.businesswire.com/news/home/20150602005185/en/

Media Contact:
Dan Budwick, Pure Communications, Inc.
973-271-6085
[email protected]
or
Investor Contact:
Susan Hager, 617-418-2258
[email protected]
or
Matt Clawson, 949-370-8500
[email protected]

Source: Foundation Medicine

You May Also Be Interested In

• William Blair Starts Surrozen Inc. (SRZN) at Outperform
• Sixty-Six Capital Expands Effective Bitcoin Exposure with Option for up to 200 BTC and Move to Direct Holdings
• FLUENT Reports Second Quarter 2026 Results